pk 11195 has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornet, S | 1 |
| Spinnewyn, B | 1 |
| Delaflotte, S | 1 |
| Charnet, C | 1 |
| Roubert, V | 1 |
| Favre, C | 1 |
| Hider, H | 1 |
| Chabrier, PE | 1 |
| Auguet, M | 1 |
| Kuhlmann, AC | 1 |
| Guilarte, TR | 1 |
2 other studies available for pk 11195 and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline.
Topics: Animals; Binding, Competitive; Brain Ischemia; Carrageenan; Corpus Striatum; Disease Models, Animal; | 2004 |
Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity.
Topics: Animals; Autoradiography; Biomarkers; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Agents; D | 1999 |